(Q42251464)

English

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study

scientific article published on 3 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

object named as

J Rance

2

0 references

object named as

C Treloar

1

0 references

author name string

G J Dore

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

J Grebely

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ETHOS Study Group

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

3 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

560-567

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

What is killing people with hepatitis C virus infection?

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Market uptake of new antiviral drugs for the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Public health impact of antiviral therapy for hepatitis C in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Rate and predictors of treatment prescription for hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Limited uptake of hepatitis C treatment among injection drug users

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Management of HCV and HIV infections among people who inject drugs

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Barriers to the treatment of hepatitis C. Patient, provider, and system factors

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Barriers to hepatitis C treatment

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Hepatitis C treatment for injection drug users: a review of the available evidence

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Successful integration of hepatitis C evaluation and treatment services with methadone maintenance

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Using thematic analysis in psychology

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Hepatitis C treatment experiences and decision making among patients living with HIV infection.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

The importance of being authentic: persuasion, narration, and dialogue in health communication and education

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Integrating HCV services for drug users: a model to improve engagement and outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Outreach screening of drug users for cirrhosis with transient elastography.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12183

21 January 2018

Identifiers

10.1111/JVH.12183

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42251464&oldid=1940134035"